What is the dosage of fenofibrate for high cholesterol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended dosage of fenofibrate for high cholesterol is 48-145 mg once daily, with the specific dose depending on the formulation used, and should not exceed 54 mg/day in patients with moderate renal impairment [eGFR between 30 and 59 mL/min per 1.73 m2] 1.

Key Considerations

  • The dosage of fenofibrate may vary depending on the specific formulation used, such as standard fenofibrate (Tricor) or micronized fenofibrate (Lofibra) 1.
  • Patients with moderate renal impairment should have their dose limited to 54 mg/day, and those with severe renal impairment (eGFR <30 mL/min per 1.73 m2) should not use fenofibrate at all 1.
  • Regular monitoring of renal function, including serum creatinine and eGFR, is essential during fenofibrate treatment 1.

Administration and Monitoring

  • Fenofibrate should be taken with food to enhance absorption.
  • Baseline liver function tests should be performed before starting treatment, and regular monitoring of lipid levels and liver function is recommended during treatment.
  • Fenofibrate works by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha), which increases the breakdown of triglycerides and raises HDL (good) cholesterol levels.

Special Considerations

  • Common side effects of fenofibrate include digestive issues, muscle pain, and potential liver enzyme elevation.
  • Patients with severe kidney disease should use lower doses or avoid fenofibrate altogether.
  • The benefits of fenofibrate in reducing ASCVD risk or triglyceride levels should be weighed against the potential risks of adverse effects, particularly in patients with renal impairment 1.

From the FDA Drug Label

DOSAGE AND ADMINISTRATION Primary hypercholesterolemia or mixed dyslipidemia: Initial dose of 160 mg once daily. Severe hypertriglyceridemia: Initial dose of 54 mg to 160 mg once daily. Maximum dose is 160 mg.

The dosage of fenofibrate for high cholesterol is 160 mg once daily for primary hypercholesterolemia or mixed dyslipidemia, and 54 mg to 160 mg once daily for severe hypertriglyceridemia, with a maximum dose of 160 mg 2.

From the Research

Dosage of Fenofibrate for High Cholesterol

The dosage of fenofibrate for high cholesterol can vary depending on the specific formulation and the patient's condition.

  • According to the study 3, fenofibrate was administered at a dose of 160-200 mg/day.
  • Another study 4 used a dose of 200 mg/day of fenofibrate.
  • A study published in 2001 5 used a dose of 200 mg/day of fenofibrate.
  • The study 6 used a dose of 200 mg/day of micronized fenofibrate.
  • The study 7 also used a dose of 200 mg/day of micronized fenofibrate.

Key Findings

  • Fenofibrate has been shown to be effective in reducing triglyceride levels and improving LDL subfraction distribution 4, 5, 6.
  • The medication has also been found to increase HDL cholesterol levels and improve vascular reactivity 5, 7.
  • The dosage of 200 mg/day appears to be a common and effective dose for fenofibrate in the treatment of high cholesterol 3, 4, 5, 6, 7.

Related Questions

What are the implications of a 40-year-old male on oxcarbazepine (Oxcarbazepine) presenting with hypercholesterolemia, normal high-density lipoprotein (HDL) cholesterol, hypertriglyceridemia, hyperlow-density lipoprotein (LDL) cholesterol, elevated cholesterol/HDL ratio, and elevated non-HDL cholesterol?
What adjustments should be made to the current atorvastatin (statin) and fenofibrate (fibrate) regimen for a patient with elevated LDL cholesterol and an unfavorable lipid profile?
Can atorvastatin (lipitor) and fenofibrate (tricor) be prescribed together?
What is the best treatment plan, including pharmacological and non-pharmacological interventions, for a 48-year-old male with hypertriglyceridemia (Trig 195), low high-density lipoprotein (HDL) cholesterol (28), elevated low-density lipoprotein (LDL) cholesterol (122), elevated hematocrit (Hct) (53.1), macrocytosis (mean corpuscular volume (MCV) 100), and mildly elevated bilirubin (Bili) (1.7), who is currently taking testosterone replacement therapy (TRT)?
What is the treatment for a 61-year-old woman with hypertriglyceridemia (elevated triglycerides), hypercholesterolemia (elevated total cholesterol), and elevated low-density lipoprotein (LDL) cholesterol?
Is Contrave (bupropion and naltrexone) safe for patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?
Is Glucophage (metformin) safe to use in patients with G6PD (glucose-6-phosphate dehydrogenase) deficiency?
What is the recommended course of Vimovo (esomeprazole/naproxen) for a patient with Juvenile Idiopathic Arthritis (JIA)?
What is the recommended treatment plan for asthma patients with elevated fractional exhaled nitric oxide (FeNO) levels?
Can a patient with heart failure receive both Spironolactone and Amiodarone?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.